Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer
Crossref DOI link: https://doi.org/10.1245/s10434-016-5704-3
Published Online: 2016-12-19
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Medina-Franco, Heriberto
Cortés-González, Rubén
Lambreton-Hinojosa, Fernando
Fimbres-Morales, Adrián
Vargas-Siordia, Juan-Carlos
License valid from 2016-12-19